These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7880725)

  • 1. Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract.
    Enomoto T; Fujita M; Cheng C; Nakashima R; Ozaki M; Inoue M; Nomura T
    Br J Cancer; 1995 Mar; 71(3):462-7. PubMed ID: 7880725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCC genetic alterations and expression in endometrial carcinoma.
    Ronnett BM; Burks RT; Cho KR; Hedrick L
    Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of DCC gene expression during ovarian tumorigenesis: relation to tumour differentiation and progression.
    Saegusa M; Machida D; Okayasu I
    Br J Cancer; 2000 Feb; 82(3):571-8. PubMed ID: 10682668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the expression of the gene deleted in colorectal carcinoma in ovarian carcinoma].
    Li PL; Liu MM; Ni J
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):207-9. PubMed ID: 12885365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation.
    Schmitt CA; Thaler KR; Wittig BM; Kaulen H; Meyer zum Büschenfelde KH; Dippold WG
    Br J Cancer; 1998 Feb; 77(4):588-94. PubMed ID: 9484816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and loss of heterozygosity of DCC gene in human lung cancer].
    Zhang J; Ding F; Wang X
    Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):211-3, 254-5. PubMed ID: 7788550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent reduction or loss of DCC gene expression in human osteosarcoma.
    Horstmann MA; Pösl M; Scholz RB; Anderegg B; Simon P; Baumgaertl K; Delling G; Kabisch H
    Br J Cancer; 1997; 75(9):1309-17. PubMed ID: 9155051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCC gene alteration in human endometrial carcinomas.
    Gima T; Kato H; Honda T; Imamura T; Sasazuki T; Wake N
    Int J Cancer; 1994 May; 57(4):480-5. PubMed ID: 7514150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma.
    Saegusa M; Hashimura M; Hara A; Okayasu I
    Cancer; 1999 Jan; 85(2):453-64. PubMed ID: 10023715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.
    Gao X; Honn KV; Grignon D; Sakr W; Chen YQ
    Cancer Res; 1993 Jun; 53(12):2723-7. PubMed ID: 8504411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential.
    Iino H; Fukayama M; Maeda Y; Koike M; Mori T; Takahashi T; Kikuchi-Yanoshita R; Miyaki M; Mizuno S; Watanabe S
    Cancer; 1994 Mar; 73(5):1324-31. PubMed ID: 7906606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of heterozygosity at the deleted in colorectal carcinoma gene locus and its association with histologic phenotypes in breast carcinoma.
    Kashiwaba M; Tamura G; Ishida M
    Virchows Arch; 1995; 426(5):441-6. PubMed ID: 7633654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer.
    Sturlan S; Kapitanović S; Kovacević D; Lukac J; Spaventi S; Spaventi R; Pavelić K
    J Mol Med (Berl); 1999 Mar; 77(3):316-21. PubMed ID: 10090594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DCC gene product in cellular differentiation and colorectal tumorigenesis.
    Hedrick L; Cho KR; Fearon ER; Wu TC; Kinzler KW; Vogelstein B
    Genes Dev; 1994 May; 8(10):1174-83. PubMed ID: 7926722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.
    Bamias AT; Bai MC; Agnantis NJ; Michael MC; Alamanos YP; Stefanaki SV; Razi ED; Skarlos DV; Kappas AM; Pavlidis NA
    Cancer Invest; 2003 Jun; 21(3):333-40. PubMed ID: 12901278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant.
    Yoshida Y; Itoh F; Endo T; Hinoda Y; Imai K
    Int J Cancer; 1998 Dec; 79(6):634-9. PubMed ID: 9842974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
    Lassus H; Salovaara R; Aaltonen LA; Butzow R
    Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of endometrial carcinoma cell tumorigenicity by human chromosome 18.
    Yamada H; Sasaki M; Honda T; Wake N; Boyd J; Oshimura M; Barrett JC
    Genes Chromosomes Cancer; 1995 May; 13(1):18-24. PubMed ID: 7541639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphoma.
    Younes A; Zhao S; Jendiroba D; Kleine HD; Cabanillas F; Andreeff M
    Blood; 1995 May; 85(10):2813-6. PubMed ID: 7742542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.